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7 ABSTRACT: A new, simple-to-implement and quantitative approach to
8 assessing the conﬁdence in NMR-based identiﬁcation of known meta-
9 bolites is introduced. The approach is based on a topological analysis of
10 metabolite identiﬁcation information available from NMR spectroscopy
11 studies and is a development of the metabolite identiﬁcation carbon eﬃ-
12 ciency (MICE) method. New topological metabolite identiﬁcation indices
13 are introduced, analyzed, and proposed for general use, including topo-
14 logical metabolite identiﬁcation carbon eﬃciency (tMICE). Because known
15 metabolite identiﬁcation is one of the key bottlenecks in either NMR-
16 spectroscopy- or mass-spectrometry-based metabonomics/metabolomics
17 studies, and given the fact that there is no current consensus on how to
18 assess metabolite identiﬁcation conﬁdence, it is hoped that these new
19 approaches and the topological indices will ﬁnd utility.
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1. INTRODUCTION
23 Metabolic proﬁling of animal and human bioﬂuids and tissues
24 is emerging as a key technology in biology and especially in
25 medicine,1 where it can be used in either a diagnostic or prog-
26 nostic mode. These metabonomics2,3 or metabolomics4 studies
27 are typically executed with NMR-spectroscopy- or mass-
28 spectrometry-based technologies for metabolite identiﬁcation
29 in bioﬂuids, cell extracts, or tissue samples. There are many steps
30 in a metabonomics experiment, and most of these steps have
31 well-described protocols for NMR-5−9 or mass-spectrometry
32 (MS)-based10−14 approaches and well-accepted statistical pro-
33 cedures15−20 for their analysis, with the signiﬁcant exception of
34 known metabolite identiﬁcation. This remains a problematic
35 step for both NMR-spectroscopy-21−25 or mass-spectrometry
36 MS-based10,26,27 metabonomics. The problem is essentially one
37 of complexity and diversity. In contrast with the 4 diﬀerent bases
38 in the nucleotides of DNA and the 20 natural amino acids in
39 protein structures, there are thousands of structurally diverse,
40 metabolites in bioﬂuids,23 and their identiﬁcation is not straight-
41 forward by NMR or MS.
42 New approaches to NMR- and MS-based known metabo-
43 lite identiﬁcation are emerging,25,28 including new database and
44 chemical treatment approaches. The new database approaches
45 include: (i) a new isomer-speciﬁc database, 1H(13C)-TOCCA-
46 TA, for the identiﬁcation of metabolites from TOCSY and
47 natural abundance HSQC-TOCSY spectra,29 (ii) a new, uniﬁed
48 and isomer-speciﬁc, database interrogation method that provides
49improved HSQC-based metabolite identiﬁcation performance
50(COLMAR),30 and (iii) SpinCouple,31 a new database for the
51analysis of the J-resolved spectra of metabolite mixtures, which
52contains a much larger number of spectra of metabolite stan-
53dards than the similar BirminghamMetabolite Library (BML).32
54The isomer-speciﬁc features of 1H(13C)-TOCCATA andCOLMAR
55are useful because they overcome the problem of failure to
56identify a metabolite if only the peaks from the high abundance
57isomer are observed, leading to low scores in overall metabolite
58matching algorithms because the low abundance isomer peaks
59are not scored. In addition, COLMAR contains useful conﬁdence
60terms including a peak matching ratio and a peak uniqueness
61statistic that decrease false-positives. To provide an orthogonal
62method for metabolite conﬁrmation, Bingol and Brüschweiler33
63developed a method called NMR/MS Translator that conﬁrms
64metabolite identiﬁcations from the HSQC COLMAR database
65by predicting the MS adduct ions that should be observed from
66the metabolites.
67Metabolite identiﬁcation is actually a problem in two distinct
68categories: ﬁrst, the de novo structure elucidation of novel meta-
69bolites identiﬁed for the ﬁrst time, and second, the structure
70conﬁrmation of known metabolites that have been identiﬁed
71and characterized previously. To elucidate the structure of novel
72metabolites, it is generally accepted that the rigorous processes
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73 used in the ﬁeld of natural product structure elucidation are
74 required.34 This would typically involve the isolation of the novel
75 metabolite from the biological matrix and its puriﬁcation ahead of
76 full molecular structure elucidation by a panoply of spectroscopic
77 techniques. See Supplementary Table S1 for a list of the struc-
78 tural features that can be revealed by these diﬀerent technologies.
79 By contrast, the structure conﬁrmation of the identities of
80 knownmetabolites is generally accepted to require a less rigorous
81 process because the structure has already been elucidated
82 and spectroscopic data on the pure metabolite may be available.
83 However, there is little consensus on what the identiﬁcation
84 process for known metabolites should be. To address this
85 problem, the Metabolomics Standards Initiative (MSI)35 set
86 up a Chemical Analysis Working Group (CAWG) in 2007.36
87 This group developed a four-level classiﬁcation scheme for the
88 identiﬁcation of known metabolites: (1) Identiﬁed Compounds,
89 (2) Putatively Annotated Compounds, (3) Putatively Charac-
90 terized Compound Classes, and (4) Unknown Compounds.
91 To reach Level 1, Identiﬁed Compounds, the following require-
92 ments were stated: “A minimum of two independent and
93 orthogonal data relative to an authentic compound analyzed
94 under identical experimental conditions are proposed as
95 necessary to validate non-novel metabolite identiﬁcations
96 (e.g. retention time/index and mass spectrum, retention time
97 and NMR spectrum, accurate mass and tandem MS, accurate
98 mass and isotope pattern, and full 1H or 13C NMR, 2-D NMR
99 spectra). The use of literature values reported for authentic
100 samples by other laboratories is generally believed to be
101 insuﬃcient to validate a conﬁdent and rigorous identiﬁcation.
102 The use of literature or external laboratory data results in level
103 2 identiﬁcations.36 Thus, the CAWG stipulated that any known
104 metabolite identiﬁcation made by reference to an authentic
105 standard in a database such as the HumanMetabolome Database
106 (HMDB),37 the BioMagResBank (BMRB),38 and the Birming-
107 hamMetabolite Library (BML)32 or to a literature report should
108 be downgraded to Level 2, Putatively Annotated Compounds,
109 whereas, if that same metabolite had been identiﬁed by reference
110 to an authentic standard, actually in the laboratory of the investi-
111 gator, it would be classed as Level 1, Identiﬁed Compound.
112 The original CAWG recommendations have not been widely
113 adopted,39 and recently new outline proposals have emerged40−43
114 for improvements to the original four-level metabolite identi-
115 ﬁcation classiﬁcation system. The proposals were either to
116 increase the reﬁnement of the four-level system or to introduce
117 some sort of scoring method for the acquisition of certain sorts of
118 data such as a 2D NMR. However, with the exception of some
119 proposals for accurate mass and retention time ﬁts,42 no pro-
120 posals were made as to how a match of the experimental data
121 with the standard data should be assessed. In addition, a call to
122 the community was made41 for engagement with this problem.
123 In response to this call, new quantitative proposals for Level
124 2 metabolite annotation conﬁdence using LC−MS methods
125 recently emerged from the group of Daly.44 In addition, our
126 group proposed some new, quantitative approaches to known
127 metabolite identiﬁcation conﬁdence for NMR-based metabo-
128 nomics studies including metabolite identiﬁcation carbon eﬃ-
129 ciency (MICE),45 drawing on an approach from the drug discovery
130 ﬁeld known as ligand eﬃciency.46 The MICE methodology
131 simply counts the number of pieces of metabolite identiﬁcation
132 information (MII) obtained for a metabolite in NMR-based
133 metabolite identiﬁcation (proton chemical shifts, signal multi-
134 plicities, coupling constants (2JH,H and
3JH,H), COSY connectiv-
135 ities, presence of second-order spin system, HSQC cross-peaks)
136and divides this sum total by the number of carbon atoms in the
137metabolite. The MICE metric is thus a measure of the amount of
138identiﬁcation information obtained relative to the size of the
139metabolite, as judged by the number of carbon atoms it pos-
140sesses. The following guidelines were proposed for a metabolite
141to be considered conﬁdently identiﬁed:
142(1) MICE value ≥1.0.
143(2) Experimental data are a good ﬁt to either authentic refer-
144ence standard data or literature or database values (diﬀerences
145between the experimental and the expected chemical shifts
146within±0.03 ppm for 1H and±0.5 ppm for 13C and homonuclear
147coupling constants within ±0.2 Hz).
148(3) Experimental data provide good “coverage” across all parts
149of the molecular structure of the metabolite.
150(4) Signal-to-noise ratio and resolution (actual and digital) in
151the spectra should be suﬃcient to measure the signal features
152with conﬁdence.
153(5) Care should be applied when assigning signals in crowded
154spectral regions.
155(6) HSQC data are important in metabolite identiﬁcation, as
156they provide an excellent orthogonal data source via the 13C NMR
157chemical shift, which is much more sensitive to environment that
158the proton chemical shift.
159(7) HMBC data should be used wherever possible to
160corroborate identiﬁcations that are uncertain or those that are
161critical for the biological interpretation of the experiment, that is,
162those metabolites that may be biomarkers.
163This current work now reports on a new topological approach
164to NMR-based, known metabolite identiﬁcation, which further
165develops the concepts introduced in the original MICE work.45
166The MICE and related analyses were novel, simple, and
167quantitative but had the disadvantage that a judgment had to
168be made of how well the MII measured represented the entire
169molecular structure (point 3 in the list above). This new work
170overcomes that issue, again, in a simple quantitative fashion by
171measuring the MII obtained by NMR spectroscopic methods
172for each separate molecular topology element (MTE) of the
173metabolite structure.
174Molecular frameworks and topologies can be computed in a
175number of diﬀerent ways. In the original molecular framework
176analysis by Bemis and Murcko,47 molecules without rings were
177classed as not having a framework. This causes issues for the
178analysis of endogenous metabolites, where large numbers
179have no rings. For example, in a recent comparative analysis of
180the topologies of human metabolites relative to drugs, natural
181products, and other molecules, only one-third of the 6237 human
182metabolites identiﬁed in the HMDB were classed as having a
183framework; that is, the majority of the human metabolites had
184a structure that comprised one or more chains of atoms.48
185This methodology is therefore unsatisfactory: Any topological
186analysis of metabolites must address the particular structural
187features that they possess. To avoid this issue, the analysis
188reported here pragmatically classiﬁes themetabolites under study
189as possessing one or more MTEs of just two types, rings and
190chains, each containing protonated and nonprotonated carbon
191atoms and slow-exchanging amide protons, as these are the
192elements that give rise to signals in 1H NMR spectroscopy-based
193metabonomics experiments.
194Metabolites may possess a single MTE, being a chain or ring,
195or may possess multiple MTEs separated by, for example, hetero-
196atomswithout slow-exchanging hydrogens, by quaternary carbons,
197or by methine (CH) carbon branching points in the structure.
198Simplicity,manageability, and applicability toNMR-basedmetabolite
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199 proﬁling have been taken into account, as well as the possibility
200 for automation, in the design of the entire analysis.
201 Topological metabolite identiﬁcation carbon eﬃciency
202 (tMICE) is shown to provide a simple, robust, and quantitative
203 measure of the conﬁdence of NMR-based identiﬁcation of known
204 metabolites in complex biological matrices.
2. MATERIAL AND METHODS
2.1. Biological Samples, Metabolites, and NMR
205 Spectroscopy
206 The 100 metabolites included in this study were recently
207 identiﬁed from ethically approved studies of the proton NMR
208 spectra of the urine of male, wildtype, and ﬂavin monooxygenase
209 5 knockout C57BL/6 mice49 and of Italian Type 2 diabetic
210 patients (Supplementary Table S2). This metabolite set is based
211 on that recently reported, and the sample preparation details
212 and NMR spectroscopy data acquisition parameters are also as
213 previously reported.45 The original set of 75 metabolites was
214 augmented by additional metabolites identiﬁed in the past
215 12 months. The methods of identiﬁcation of the metabolites
216 were as previously reported.45
2.2. Analysis of Metabolite Features
217 The following information was abstracted for each metabolite
218 and is provided in Supplementary Table S2:
219 (1) metabolite class
220 (2) metabolite common name
221 (3) metabolite IUPAC name
222 (4) HMDB code
223 (5) number of hydrogen atoms
224 (6) number of carbon atoms
225 (7) number of oxygen atoms
226 (8) number of nitrogen atoms
227 (9) number of sulfur atoms
228 (10) total number of heavy atoms (non-hydrogen atoms)
229 (11) nominal molecular mass in Daltons
230 (12) a ﬂag for molecular symmetry: 1 = some element of
231 symmetry is present in metabolite; 0 = no symmetry element in
232 metabolite
233 (13) a ﬂag for chirality: 1 = ≥1 chiral centers; 0 = 0 chiral
234 centers in metabolite
2.3. Deﬁnition of Molecular Topology Elements and Atom
235 Numbering
236 MarvinSketch was used for drawing, displaying, and character-
237 izing chemical structures, and topology elements, Marvin 6.1.1,
238 2013, ChemAxon (http://www.chemaxon.com).
239 MTEs were analyzed by hand for all of the metabolites in the
240 study, and a full list of the metabolites, their assigned MTEs, and
241 their MII is provided in Supplementary Table S3. The following
242 methodology and logic was applied:
243 (1) MTEs are deﬁned to be of two basic types: rings of atoms
244 (code 0) and chains of atoms (code 1).
245 (2) For simplicity and practicality of application, ring
246 structures are treated as singular topology elements.
247 (3) The ﬁrst molecular topology element, MTE1, will be the
248 highest priority chain or ring according to IUPAC50 functional
249 group and Cahn−Ingold−Prelog51 (CIP) priorities, the latter
250 determining priorities based on the atomic number of the
251 substituent (S > O > N > C > H, etc.) and on bond multiplicities
252 with, for example, CO treated as C(O)−O; that is, a carbon
253 with a double bond to oxygen is treated as if it has two single
254 bonds to two separate oxygen atoms.
255(4) For molecules containing chains of atoms: (a) Breaks
256between topology elements will occur af ter quaternary carbons
257or heteroatoms without nonexchanging hydrogens, as these
258atoms interrupt the proton-to-proton connectivity information
259available from experiments such as 2D 1H COSY NMR.52 (b) If
260the start point of any MTE is a quaternary carbon it will not
261break; for example, there is not a break after the starting
262carboxylic acid carbon (C1) in (S)-lactic acid. The single, chain-
263type MTE1 goes from the C1 carboxylic acid carbon through C2
264to chain termination at the methyl group, C3.
265(c) The numbering of any subsequent MTE will start at the ﬁrst
266atom after the break point: The breaking quaternary carbon or
267heteroatom is included in the preceding MTE. (d) The number of
268branches after a quaternary carbon will generally equal the number
269of atoms bonded to that quaternary carbon minus 1, and the pri-
270ority for the nextMTEwill be given again byCIP rules. For example,
271the start point forMTE1 in cis-aconitic acid is the carboxylic acid car-
272bon located on the central sp2 carbon. This carboxylic acid carbon is
273followed by an sp2 quaternary carbon with two branches, which go
274ﬁrst to theCH−COOH(MTE2) and then second to the−CH2−
275COOH (MTE3) groups by CIP priority rules. The boundaries
276between MTEs are shown by dashed lines in the structures.
277(e) If there is a branching point that is a methine carbon (CH),
278the MTE will move across the branch point according to CIP
279priority rules and will continue until chain termination or arrival
280at a break point. If the chain terminates, the next MTE will then
281be decided by CIP rules. On the contrary, if one or more new
282chains continue after a break point, then a structural path
283continuation rule applies and the subsequent MTE will carry
284on the same path at that point (see 5 below). For example,
285phenylacetylglutamine branches at the −CH− (C2) of MTE1
286(HOOC−CH−NH−CO) and continues by priority via N3 to
287the amide carbonyl carbon break point (C4).
288The singlemethylene unit then becomesMTE2 as it continues the
289chain (rule 5 below) and coincidentally, it is higher priority (due to
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290 its phenyl substituent) than the alternative methylene group at the
291 branching CH: The phenyl moiety becomes MTE3, and MTE4 is
292 the three carbon amide chain at the methine branching point in
293 MTE1. Another diﬀering example occurs in (2S)-isopropylmalic
294 acid, which branches at the−CH− (C1) of MTE2 (−CH−CH3),
295 so the − CH2−COOH becomes MTE3 by CIP priority and then
296 the methyl group at the branching point becomesMTE4, as this is
297 a chain termination rather than a chain continuation example.
298 (f) For metabolites with equivalent groups after a methine
299 branching point (CH), the break will be randomly to one side or
300 the other; for example, ketoleucine has two equivalent methyl
301 groups: C3 in MTE2 and C1 in MTE3.
302 (g) For equivalent carbons allocated in diﬀerent MTEs, all are
303 registered and analyzed, for example, in ketoleucine above and in
304 citric acid, dimethylamine, and trimethylamine, as it is critical that
305 the topological analysis reﬂects the totality of the metabolite
306 structure, including the possession of equivalent features.
307 (5) Structural path continuation rule: In addition to the above
308 rules regarding branching at CH and quaternary carbons, if after a
309 break point there is a choice between continuing along that
310 structural path or moving back to another structural element,
311 continuing along the structural path will take priority (even if this
312 breaks CIP priorities) to pragmatically align the MTE order with
313 themetabolite structure as closely as possible. This rule applies to
314 all metabolites, no matter of what structural type.
315 (6) For metabolites with a combination of rings and chains,
316 the ﬁrst molecular topology element, MTE1, will be also deﬁned
317 by IUPAC functional group priorities. (a) For example, MTE1
318 in 3-methylhistamine is the aminoethyl chain, MTE2 is the
319 imidazole ring, and MTE3 is the methyl group.
320(b) Ring priorities are decided by the number of heteroatoms of
321any type and if the same number, by ring size: A complex example
322is sucrose, whose six-membered ring (oxane) is MTE1; then,
323MTE2 is given by the continuation path rule to the hydro-
324xymethyl at C5. MTE3 then corresponds to the ﬁve-membered
325ring (oxolane), MTE4 to the hydroxymethyl at C4, again by
326continuation path, and MTE5 is the remaining hydroxymethyl
327at C1.
328(7) For fused rings, carbons at the fusion site will be attached
329to the ring of greatest priority (see rule 6b), and they only will be
330counted once; for example, the ﬁrst MTE in indoxyl-3-sulfate is
331the pyrrole ring (highest priority). MTE2 then corresponds to
332the remaining four aromatic CHs of the phenyl ring, excluding
333the carbons at the fusion site. The sulfate group has no observ-
334able, slow-exchanging protons and is not counted.
2.4. Determination of the Metabolite Identiﬁcation
335Information for each Molecular Topology Element
336Once the molecular topology elements (MTEs) were deﬁned,
337the experimental metabolite identiﬁcation (ID) information for
338each metabolite was extracted from analyses of the NMR spectra
339of the mouse and diabetic patient urine. In parallel, the theo-
340retical information that could possibly be obtained was calcu-
341lated. Supplementary Table S2 summarizes both the theoretical
342and experimental information that was measured for all MTEs in
343all 100 metabolites.
344The MII for each MTE consists of the following information,
345and for points 4 to 8 both actual experimental and then theo-
346retical values are calculated:
347(1) Type of MTE, coded 1 for chains and 0 for rings.
348(2) Total number of carbon atoms in the MTE.
349(3) Total number of nonexchanging NH groups in the MTE.
350(4) MTE metabolite ID information at HSQC level,45 which
351equals the sum total of the number of bits of the following
352information, where present and observed: (a) proton chemical
353shifts for each protonated carbon and nonexchanging amide NH;
354(b) multiplicity for each of these signals; and (c) coupling con-
355stants (2JHH and
3JHH) for each signal (note that this is diﬀerent
356from the original MICE methodology where nJHH values were
357only counted once: this was seen as too conservative as each is
358an independent measurement). Longer-range couplings were
359not counted as the methodology was designed to be imple-
360mented for NMR spectra with nominal resolution: (d) presence
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361 of second-order spin system (ﬂag = 1 if there are additional lines
362 present in the spectrum, not anticipated by a ﬁrst-order spectral
363 analysis, otherwise ﬂag = 0); (e) intra-MTE COSY links via 2JHH
364 and 3JHH between hydrogens (only counted once); (f) inter-MTE
365 COSY links via 3JHH between hydrogens (only counted once and
366 associated with the ﬁrst MTE connected); and (g) HSQC cross-
367 peaks for each protonated carbon atom (counted twice if measured
368 separately at each of two nonequivalent hydrogens of a methylene
369 group).
370 (5) HSQC-level tMICE values that equal the sum total of the
371 information in eachMTE (see point 4 above) divided by the total
372 number of carbon atoms.
373 (6) HMBC connectivity information is additionally provided
374 for metabolites, which enables the gathering of more information
375 about information-poor MTEs. This is especially useful in sym-
376 metrical metabolites where there can be a paucity of information.
377 The HMBC experiment can be enabling here by 13C isoto-
378 pomeric raising of the degeneracy within and between sym-
379 metrical MTEs. For example, even though chemically and
380 magnetically equivalent by symmetry, HMBC cross-peaks can be
381 observed between the methyl groups in trimethylamine due to
382 isotopomeric raising of the degeneracy of the methyl groups, as
383 the HMBC signals are observed via 3JC,H from the species
384 H3
13C−N−12CH3.
385 (7) HMBC connectivities were counted in two diﬀerent ways:
386 (1) HMBC connectivities inside an MTE were counted once
387 only and (2)HMBC connectivities betweenMTEs were counted
388 twice, at both the carbon-13 and proton that are connected. This
389 is in contrast with the original MICE analysis where HMBC
390 connectivities were counted only once. Inside an MTE, the
391 HMBC connectivity is often between hydrogens and carbon-13
392 nuclei whose chemical shifts are known from HSQC-level
393 analyses. Thus, the only new piece of information is the con-
394 nection between two known signals: Therefore, we count one
395 bit. However, inter-MTE HMBC data often provide correla-
396 tions to, or through, quaternary carbons, and when it does so,
397 it provides new information in the form of: (1) the 13C NMR
398 chemical shifts of the quaternary carbons or (2) connections
399 between two isolated MTEs. Therefore, we counted two bits of
400 information for inter-MTE HMBC connectivities, and the dif-
401 ferential counting of intra- and inter-MTE HMBC data seems
402 appropriate.
403 (8) HMBC-level tMICE+ values that correspond to the
404 number of bits of MII at HSQC level plus the total number of
405 HMBC links divided by the total number of carbon atoms (see
406 Table 3 (Glossary)).
407 (9) A value calculated by dividing the actual experimental
408 tMICE values by the corresponding theoretical values.
409 (10) As for the original MICE analysis,45 experimental MII
410 was classed as ﬁtting and therefore counted when diﬀerences
411 between the experimental and the equivalent authentic reference
412 or literature or database chemical shifts were within ±0.03 ppm
413 for 1H and ±0.5 ppm for 13C and when homonuclear coupling
414 constants were within ±0.2 Hz.
415 (11) For metabolites that are symmetrical within an MTE,
416 identiﬁcation information at the HSQC level is introduced only
417 once; for example, succinic acid has twomethylene carbon atoms
418 that are equivalent due to symmetry, but the information is only
419 recorded once, just as it is observed.
420 (12) Long-range H−H COSY information is excluded, as the
421 analysis is intended to be applicable to 2D NMR information
422 acquired with nominal resolution and sensitivity.
2.5. Determination of the Overall Metabolite Identiﬁcation
423Information for Each Metabolite
424Having computed the metabolite ID information available
425experimentally and theoretically for each MTE separately in
426each metabolite (Section 2.3), the following information was
427analyzed for each metabolite as a whole:
428(1) total number of carbon atoms in the metabolite
429(2) total number of nonexchanging NH groups in the
430metabolite
431(3) actual and theoretical total number of MII bits at HSQC
432level for all MTEs
433(4) actual and theoretical total number of inter-MTE COSY
434links in the metabolite
435(5) actual and theoretical total number of HMBC links in the
436metabolite
437(6) actual and theoretical MICE values for each metabolite
438calculated by summing the total bits of information at HSQC
439level for all MTEs of a metabolite (point 3 above) and then
440dividing by the total number of carbon atoms (point 1 above)
441(7) actual and theoretical MICE+ values for each metabolite
442were calculated by summing the total bits of information at
443HMBC level for all MTEs of a metabolite (point 3 plus 5 above)
444and then dividing by the total number of carbon atoms (point 1
445above)
2.6. Precision of Measurements of 1H NMR Chemical Shifts
446in a Variety of Metabolites in Buﬀered Mouse Urine and
447Comparison of Experimental Shifts with Those of Authentic
448Reference Standards in the HMDB
449The chemical shifts of a variety of aliphatic, oleﬁnic, and aromatic
450protons in a variety of acidic, basic, and neutral metabolites were
451measured to determine the variability of chemical shifts in these
452diﬀering environments in mouse urine from 34 individual
453C57BL/6 mice and their FMO5 KO counterparts49 at weeks 15,
45430, 45, and 60. The results are summarized in Table 1 and
455compared with the corresponding values obtained from the
456HMDB.37
2.7. Statistical Analyses of the Data
457All statistical analyses were conducted in Microsoft Excel for
458Macintosh version 14.5.5. All errors are standard deviations.
459All signiﬁcance testing used the two-tailed, unpaired Student’s
460t test with a conﬁdence threshold of >95% (p < 0.05).
3. RESULTS
3.1. Molecular Properties of the 100 Metabolites in the Set
461The 100 metabolites were in 11 classes: carboxylic acids (10),
462hydroxycarboxylic acids (6), dicarboxylic acids (9), tricarboxylic
463acids (4), small alcohols (5), ketones (2), sugars and sugar acids
464(7), amines (14), amides and amino acids (32), nucleosides and
465nucleotides (10), and others (1) for a total of 100 metabolites.
466See the Supplementary Tables S2 and S3 for more information.
467The atomic composition and molecular weight properties of the
468100 metabolites are shown in Table 2.
469Table 2 gives basic statistics for the number of hydrogen,
470carbon, oxygen, nitrogen, and sulfur atoms present in the meta-
471bolite set, including the number of metabolites possessing these
472atoms (ﬁrst row) and the statistics for the entire set in subsequent
473rows, plus basic statistics on the metabolites’ nominal molecular
474mass. While all 100 metabolites studied contained hydrogen and
475carbon, 95 contained oxygen, and 56 contained nitrogen, only 4
476of the sets contained one sulfur atom each. Further analysis
477(Supplementary Table S2) shows that 16 of the 100 metabolites
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478 possessed slow-exchanging NH groups that could potentially
479 give rise to additional signals and connectivities in their 1H NMR
480 spectra.
481 The average molecular weight of the set is 138.0 ± 54.5 Da
482 (standard deviation), and the distribution is shown in Figure 1.
3.2. Molecular Topology Elements in the Metabolites
483 Topological analysis of the set of 100 metabolites showed that
484 they possess between 1 and 5 MTEs with the distribution shown
485 in Figure 2. 67% of the metabolites possess 1 or 2 MTEs, 21%
486 possess 3, 10% possess 4, and only 2% possess 5 MTEs.
487 The 100 metabolites contained a total of 216 MTEs, of which
488 the vast majority (168, 77%) were chains. The distribution of
489 MTE types for MTEs 1 to 5 is shown in Figure 3.
490 An overview of the distribution of the topologies and their
491 types for all 100 metabolites is given in Figure 4, in the form of a
492 grid. The overwhelming preponderance of chain MTEs is clear
493 from Figures 3 and 4.
3.3. Calculation of Topological Metabolite Identiﬁcation
494 Eﬃciency Values
495 The number of bits of MII in eachMTE was measured by default
496 at the HSQC level. When this number is divided by the number
497 of carbons in the MTE, we arrive at the tMICE value for that
498 MTE, by analogy to the previously described MICE index.45
499 The outcome of the topological analysis for MTE1 and MTE2
500 for the ﬁrst 16 metabolites, the carboxylic acids, and hydro-
501 xycarboxylic acids, is shown in Figure 5. Each metabolite is asso-
502 ciated with a symmetry ﬂag and a chirality ﬂag that is each set to
503 either 0 (no symmetry or no chirality) or 1 (some element of
504symmetry or chirality, respectively). Then, eachMTE is analyzed
505separately in terms of the number of bits of MII at the HSQC
506level and the number of inter-MTE COSY links. The inter-MTE
507COSY information is, of course, included in the HSQC-level MII
508but is split out separately to give a view of how much information
509there is at this level to linkMTEs together in the samemetabolite.
510The analysis is conducted from both information derived experi-
511mentally and that which is potentially observable theoretically.
512Naturally, not all of the MII that is theoretically available is
513actually observable due to issues of low metabolite concen-
514trations or crowding in the real spectra. The tMICE values can be
515simply calculated by dividing the total number of metabolite
516identiﬁcation bits at the HSQC level in the MTE by the number
517of carbon atoms in that same MTE.
3.4. Analysis of tMICE Values for All 100 Metabolites at
518HSQC Level
519We next analyzed the tMICE values for each of the 217 MTEs in
520the 100 metabolites using the three-part triage shown below
521(Figure 6). In the subset of metabolites illustrated in Figure 5,
522it can be observed that there are three kinds of situation with
523respect to the tMICE values for the MTEs in each metabolite:
524(1) It is theoretically possible to obtain suﬃcient MII for the
525MTE to generate a tMICE of ≥1.0 (a proposed cutoﬀ threshold
526value for conﬁdent identiﬁcation of the MTE), and this is
527achieved experimentally (green).
528(2) It is theoretically possible to obtain a tMICE of ≥1.0 for
529the MTE but this is NOT achieved experimentally (red).
530(3) It is theoretically impossible to obtain a tMICE of ≥1.0
531(cyan in Figure 6).
532135 MTEs (62%) have actual tMICE values ≥1.0 (green);
53329 MTEs (13%) have actual tMICE values <1 but theoretical
534tMICE values ≥1.0 (red); and 52 MTEs (24%) have theoretical
535tMICE values <1.0 (cyan).
3.5. tMICE+ Values for all 100 Metabolites at HMBC Level
536In the tMICE+ analysis at HMBC level, 168 MTEs (77%) have
537actual tMICE+ values ≥1.0; 40 MTEs (19%) have actual tMICE
538+ values <1 but theoretical tMICE values≥1.0; and only 8MTEs
539(4%) have theoretical tMICE+ values <1.0.
540In moving from theHSQC-level tMICE analysis to the HMBC-
541level tMICE+ analysis, 27 MTEs changed from cyan (theoretical
542tMICE<1) to green (actual tMICE+≥ 1.0); 6MTEs changed from
543red (actual tMICE values <1 but theoretical tMICE values≥1.0) to
544green (actual tMICE+ ≥ 1.0), and 17 MTE changed from cyan
Table 2. Number of Metabolites Containing Hydrogen,
Carbon, Oxygen, Nitrogen and Sulphur Atoms and Statistical
Information on the Elemental Compositiona









100 100 95 56 4
maximum 17 13 8 5 1 21 297
minimum 2 1 0 0 0 2 31
mean 8.69 5.45 3.09 0.94 0.04 9.52 138.0
median 8 5 3 1 0 9 132.0
standard
deviation
3.01 2.44 1.81 1.11 0.20 3.87 54.5
aAll data for the set of 100 metabolites in this study.
Table 1. Average Experimental Chemical Shifts (n = 34), Standard Deviations, Maximum and Minimum Values, Range,
Corresponding HMDB Values, and Diﬀerences between the HMDB and Average Experimental Values for 10 Representative

















1.254 5.721 2.879 2.611 3.276 1.620 7.704 2.558 6.723 7.837
standard deviation 0.0010 0.0172 0.0028 0.0024 0.0028 0.0007 0.0030 0.0053 0.0060 0.0017
maximum value 1.256 5.752 2.885 2.616 3.282 1.622 7.710 2.570 6.734 7.840
minimum value 1.252 5.696 2.875 2.607 3.272 1.619 7.698 2.549 6.706 7.832
range in values 0.004 0.056 0.010 0.009 0.010 0.003 0.012 0.021 0.028 0.008
HMDB shift 1.25 5.693 2.893 2.59 3.253 1.613 7.712 2.527 6.706 7.820
diﬀerence HMDB vs
experimental
0.004 0.028 0.014 0.021 0.023 0.007 0.008 0.031 0.017 0.017
aTMA, trimethylamine; MA, methylamine; TMAO, trimethylamine N-oxide. The chemical shift of the second-order ortho protons of hippuric acid
was estimated at the mid-point of the complex signal. The shifts of cinnamoylglycine were obtained from an authentic Sigma reference standard, as
no data were available in the HMDB entry for this metabolite.
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545 (theoretical tMICE < 1) to red (actual tMICE+ < 1 but theo-
546 retical tMICE+ ≥ 1.0). See also Figure 7.
547 tMICE+ values for metabolites with some degree of symmetry
548 (actual 2.18 ± 1.93 and theoretical 3.49 ± 2.62, n = 79) were
549 lower than those for unsymmetrical metabolites (actual 2.68 ±
550 2.43, p = 0.101 and theoretical 7.20 ± 5.50, n = 137, p = 2.30 ×
551 10−10) but were only statistically signiﬁcantly lower for the theo-
552 retical tMICE+ values. Similarly, tMICE+ values for achiral meta-
553 bolites (actual 2.37 ± 1.90 and theoretical 3.93 ± 2.31, n = 140)
554 were lower than those for chiral metabolites (actual 2.73 ± 2.82,
555 p = 0.318 and theoretical 9.35 ± 6.51, n = 76, p = 4.82 × 10−10),
556 although again only the theoretical tMICE+ diﬀerences were
557 statistically signiﬁcant.
4. DISCUSSION
558 Conﬁdence in known metabolite assignment is one of the key
559 issues facing metabonomics/metabolomics at present. Many
560current studies do not report in detail their MS- or NMR-based
561spectroscopic analyses, let alone any assessment of the con-
562ﬁdence ratings for the identiﬁcation of important metabolites.
563The Metabolomics Standards Initiative (MSI)35 recognized
564this as an important issue as far back as 2007 and proposed a set
565of guidelines,36 but few studies currently refer to these,39 and
566improvements/amendments to the guidelines have been sug-
567gested recently.28,41−45
568There are three key issues with the current MSI guidelines for
569metabolite identiﬁcation in our view: (i) they are qualitative and
570not quantitative, referring to having data such as 2D NMR
571spectra; (ii) there is no guidance on how good a ﬁt of the
572experimental data to reference data should be; and (iii) there is
573an assertion that data in the literature or in databases such as the
574HMDB are “generally believed insuﬃcient to validate a conﬁdent
575and rigorous identiﬁcation”.36 The work reported here addresses
576these issues. First, both the recent MICE and the new tMICE
577methods presented here are quantitative in basis but simple and
578easy to calculate. Second, clear guidance is given on the goodness
579of ﬁt required for experimental NMR data to be seen as a
580good match for literature or reference standard data. Third, the
581assumption that data generated from a reference standard of a
582metabolite in the investigator’s laboratory will be signiﬁcantly
583diﬀerent from that recorded on a diﬀerent sample of that standard
584in the literature or in a database such as the HMDB is shown to
585be generally incorrect for NMR-based metabonomics (Table 1).
586This may be an issue and a concern for MS-based experiments
587such as UPLC−MS or LC−MS, where, for example, metabolite
588retention time could be inﬂuenced by a number of factors including
589the exact column type, history and age, and mass spectral inten-
590sities could be inﬂuenced by sample- and spectrometer-speciﬁc
591ion suppression and enhancement eﬀects, in addition to diﬀerential
Figure 1. Histogram of the distribution of molecular weights of the 100 metabolites in the set.
Figure 2. Chart of the number of metabolites with 1, 2, 3, 4, or 5 MTEs in the 100 metabolites studied.
Figure 3. Chart of the distribution of chains or rings across MTEs 1 to 5
in the 100 metabolites in the current cohort.
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592 adduct formation.10 However, in general, these concerns will not
593 apply to 1H and 13C NMR spectroscopy data. With the exception
594 of a minority of metabolites that have spectral characteristics that
595 are particularly sensitive to the exact sample environment, the
596 vast majority of metabolites have NMR spectral data that match
597 very well the corresponding information on authentic standards
598 under equivalent conditions in databases such as the HMDB.
599 Indeed, if this was not the case, there would be little purpose in
600 assembling these databases in the ﬁrst place. Moreover, NMR
601 data on metabolites are inherently quantitative (given certain
602 provisos), are generally referenced to the same or highly similar
603 chemical shift reference standards, and are not subject to the
604 instrument/technique-speciﬁc changes in data that can be
605 observed in MS between diﬀerent ionization methods and dif-
606 ferent detection systems. Finally, it has been known for some
607 time that the analytical variability of NMR-based metabonomics
608 studies is low.53−56
609 In practice, of course, some diﬀerences in chemical shifts will
610 occur, especially for 1H or 13C nuclei in metabolites that are
611 subject to tautomerism or ionization changes with alteration in
612 solvent/medium pH. To test this variability, we measured the
613 chemical shifts of ten diﬀerent hydrogen types in a variety of
614 acidic, basic, and neutral metabolites in 34 independent mouse
615 urine samples (Table 1). The largest range of shift values observed
616for one hydrogen environment was that for the oleﬁnic CH
617proton of cis-aconitic acid, which showed a value of 5.721± 0.017
618ppm (mean ± standard deviation) and a range of 0.056 ppm.
619Surprisingly, these values were greater than those for the low-
620frequency methylene proton signal from citrate: 2.558 ± 0.005
621ppm, with a range of 0.021 ppm. As expected, the chemical shifts
622of the methylene protons in N-butyrylglycine at 1.620 ± 0.001
623ppm with a range of only 0.003 ppm were almost invariant
624across all of the samples. The shifts of other metabolites such
625as trimethylamine were intermediate in variability at 2.879 ±
6260.003 ppm, range 0.010 ppm. Nevertheless, the data showed that
627(assuming normal distribution) even for the sensitive cis-aconitic
628acid oleﬁnic proton shifts >95% of values are expected to occur in
629a range of ±0.034 ppm (two times the standard deviation)
630around the mean, and all 34 experimental values do. For the
631intermediate case of trimethylamine, >95% of values would be
632expected to occur in a range of ±0.006 ppm around the mean,
633and all 34 values do.
634The experimental chemical shift values were then compared
635with the corresponding HMDB values (or in the single case of
636cinnamoylglycine, an actual reference standard run on our spec-
637trometers, as there are no data in HMDB). For the 10 hydrogen
638environments studied, the diﬀerences between the mean experi-
639mental mouse values and theHMDB37/reference values (Table 1)
Figure 4. Simpliﬁed depiction of the MTE composition in terms of chains (blue, 1) or rings (pink, 0) for all 100 metabolites in the set.
Figure 5. Experimental and theoretical metabolite identiﬁcation information from NMR for MTEs 1 and 2 for the ﬁrst 16 metabolites in the set of 100:
the carboxylic acids and hydroxycarboxylic acids. MII = metabolite identiﬁcation information. The tMICE values are color coded according to magni-
tude from low (red) to high (green). Theor. = theoretical. See the text for description and Table 3 (Glossary) for a full explanation of all terms. The entire
table is available as Supplementary Table S2.
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640 varied from a low of 0.004 ppm (methyl protons in β-D-fucose)
641 to a high of 0.031 ppm for the high-frequency methylene proton
642 in citric acid, with an average diﬀerence of 0.017 ± 0.009 ppm
643 (standard deviation). Our proposal that comparisons of experi-
644 mental data can be conﬁdently made with reference standard
645 data from databases such as the HMDB rather than generat-
646 ing new NMR data on an authentic reference standard on the
647 same spectrometer seems valid. In addition, the guideline of
648 matching proton chemical shifts between experimental data
649 and database or literature values of ±0.03 ppm also seems
650 reasonable.
651 The group of 100 metabolites studied here is typical of
652 those identiﬁed by NMR spectroscopy in metabonomics studies.
653These 100 metabolites have a molecular weight distribution as
654follows: 138.0± 54.5 Da in this set versus 126.7± 46.6 Da for the
655set of 75 subjected to MICE analysis.45 Correspondingly, the
656number of carbon atoms in the metabolites in this set is 5.5± 2.4
657versus 4.9 ± 2.2 atoms previously (all ﬁgures means ± standard
658deviations). These changes are due to the fact that further work
659had identiﬁed metabolites that were less obvious in the year since
660the previous analysis was completed. These less obvious meta-
661bolites generally had larger and more complex structures with
662increased molecular weight.
663The topological approach to metabolite identiﬁcation intro-
664duced here is a natural approach for NMR spectroscopy. Net-
665works of proton-to-proton connectivity that are discovered by
Figure 6. Analysis of the tMICE value for each MTE in each of the 100 metabolites at the HSQC level. Green: actual tMICE value ≥1.0; red: tMICE
actual <1.0 but tMICE theoretical ≥1.0; cyan: tMICE theoretical <1.
Figure 7. Left: Histogram of the distribution of HSQC-level tMICE values in MTEs: Green: actual tMICE value ≥1.0; red: tMICE actual <1.0 but
tMICE theoretical ≥1.0; cyan: tMICE theoretical <1.0. Right: Corresponding HMBC-level tMICE+ analyses with analogous color coding.
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666 methods such as 2D 1H COSY NMR are frequently broken or
667 interrupted by so-called “spectroscopically silent centers” such as
668 heteroatoms bearing no slow-exchanging protons or quaternary
669 carbons. The topological analysis deﬁnes these “spectroscopi-
670 cally silent centers” as two of the four types of break between
671 the MTEs in the structure of the metabolite, with the other two
672 breaks betweenMTEs being ring junctions and branchingmethine
673 carbons. Thus, in this analysis, there tends to be a natural align-
674 ment between the topology elements in the metabolites and
675 subnetworks of proton−proton connectivity derived from the
676 NMR spectra.
677 The basic tMICE approach measures the number of bits of
678 MII derived from NMR spectra from each MTE at a level up to
679 2D 1H, 13C HSQC, that is, information gathered from 1D
680
1H NMR, 2D 1H J-resolved NMR, 2D 1H COSY NMR, and 2D
681
1H, 13C HSQC experiments. These bits of information include
682 the following: (1) the number of proton chemical shifts for
683 each protonated carbon and nonexchanging amide NH; (2) the
684 number of signal multiplicities identiﬁed (usually from 1D
685
1H NMR or 2D 1H J-resolved NMR); (3) the number of
686 coupling constants measured (2JHH and
3JHH) for each signal
687 (note that this is diﬀerent from the original MICE methodology
688 where nJHH values were only counted once: this was seen as
689 too conservative); (4) the presence of second-order spin system
690 (ﬂag = 1 if there are additional lines present in the spectrum, not
691 anticipated by a ﬁrst-order spectral analysis, otherwise ﬂag = 0;
692 the bit is only counted if it is set to 1); (5) the number of intra-
693 MTE COSY links via 2JHH and
3JHH between hydrogens (only
694 counted once) and the number of inter-MTE COSY links via
695
3JHH between hydrogens (only counted once and associated with
696 the ﬁrst MTE connected); and (6) the number of HSQC cross-
697 peaks for each protonated carbon atom (counted twice if mea-
698 sured separately at nonequivalent hydrogens of a methylene
699 group). The sum total number of bits of information for each
700 MTE is then divided by the number of carbon atoms in thatMTE
701 to give the tMICE value.
702 For example, simple metabolites like propanoic acid just have
703 one chain-class MTE from C1O to C3H3.
704 In this case, a total of seven bits of MII were experimentally
705 observed (see Figure 5): two 1H chemical shifts (1.061, C3H3
706 and 2.190 ppm, C2H2), two
1H signal multiplicities (triplet
707 and quartet), two 3JHH coupling constants (7.7 and 7.7 Hz),
708 and a COSY between the signals for the methyl and methylene
709 groups, all matching the values given for the authentic meta-
710 bolite HMDB00237 to within ±0.03 ppm and ±0.2 Hz for
711
1H chemical shifts and coupling constants, respectively
712 (1.04 and 2.17 ppm, 7.7 Hz, all for a 10 mM sample at pH
713 7.0 in H2O referenced to DSS, accessed from HMDB on
714 April 25, 2016).37 With three carbons in the single MTE for
715 propanoic acid, this gives it a tMICE value of 7/3 = 2.3. Theo-
716 retically, at an HSQC level, two 13C chemical shifts could have
717 been observed, but these were below the sensitivity of our
718 experiment and were not observed. The theoretical tMICE
719 value is 9/3 = 3.0.
720 Slightly more complex metabolites like isovaleric acid were
721 characterized as follows.
722In MTE1 (four carbons) of isovaleric acid, a total of eight
723bits of information were experimentally obtained at an HSQC
724level, including two 1H shifts, two multiplicities, two coupling
725constants, one 13C shift, and one COSY connectivity (0.916, d,
7266.6 Hz, 24.8 ppm with COSY to 1.958, multiplet and 2.062, d,
7277.4 Hz), matching that of the authentic metabolite HMDB00718
728(0.90, d, 6.6 Hz, 24.7; 1.94, triplet of septet (HMDB erroneously
729has doublet of quartet), 7.9, 6.6 Hz and 2.045, d, 7.5 Hz (HMDB
730erroneously gives 0.5 Hz?), all for pH 7.0 in H2O referenced to
731DSS (n.b. the raw free induction decay data ﬁles associated with
732this entry in the HMDB are for another unrelated metabolite)
733accessed on April 25, 2016).37 Note that the signal for the methine
734proton H3 is a very weak 1-proton triplet of septets and was only
735observed indirectly in the COSY and is therefore not included in
736the chemical shift or multiplicity counts. ForMTE2, the symmet-
737rically equivalent methyl group, no information was obtained
738and, at an HSQC level, no MII can be obtained because of equiv-
739alence. The tMICE values are thus 2.0 (8/4) and 0 forMTE1 and
740MTE2, respectively. The errors found in theHMDB data analysis
741do highlight the importance of checking database entries for the
742quality of the sample, the spectrum, and the data analysis.
743The analysis of isovaleric acid highlights the importance of the
744topological approach to known metabolite identiﬁcation con-
745ﬁdence. While the main portion of the metabolite is well iden-
746tiﬁed, there is no information available on the second methyl
747group in MTE2 due to molecular symmetry and equivalence.
748The HSQC-level tMICE information was analyzed separately
749for diﬀerent overall classes of metabolite. tMICE values for meta-
750bolites with some degree of symmetry (actual 1.26 ± 1.30 and
751theoretical 1.87 ± 1.72, n = 79) were statistically signiﬁcantly
752lower than those for unsymmetrical metabolites (actual 1.97 ±
7531.94, p = 0.0015 and theoretical 3.88 ± 3.53, n = 137, p = 6.45 ×
75410−8). It is natural that the tMICE values of the metabolites with
755some element of symmetry are lower than those of metabolites
756without symmetry, as in the metabolites with symmetry, there
757will be elements of the structure for which it will not be possible
758to obtain independent NMR data. For example, in dimethyl-
759amine, the two methyl groups are chemically equivalent by
760symmetry and at an HSQC level it is not possible to get infor-
761mation separately from these MTEs. Even though both methyl
762groups contribute to the singlet signal at 2.720 ppm, the infor-
763mation is ascribed solely to MTE1, and the second methyl group
764inMTE2 is allocated no bits ofMII. This is a conservative approach
765and reﬂects what is actually observed.
766Similarly, tMICE values for achiral metabolites (actual 1.52 ±
7671.42 and theoretical 2.08 ± 1.54, n = 140) were lower than those
768for chiral metabolites (actual 2.04 ± 2.23, p = 0.067 and theo-
769retical 5.11 ± 4.24, n = 76, p = 4.14 × 10−8), although only the
770theoretical tMICE diﬀerences were statistically signiﬁcant; the
771actual tMICE diﬀerences are just insigniﬁcant. This eﬀect is
772due to the chiral center causing nonequivalence of the geminal
773protons on the methylene carbons in chiral metabolites. In chiral
774metabolites, each geminal proton typically resonates at a distinct
775frequency, thus doubling the amount of information available
776from, and to, these groups.
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777 The key factor in the identiﬁcation of known metabolites is
778 whether suﬃcient information has been collected to be conﬁdent
779 in the identiﬁcation. The tMICE approach enables this analysis
780 to be done quantitatively for each separate topology element in
781 the metabolite, but the question is still, how much information is
782 enough? Following on from the original MICE work where
783 an overall value of MICE ≥ 1.0 was determined to be generally
784 suﬃcient to conﬁdently identify a metabolite,45 we chose to have
785 a tMICE value of≥1.0 also as the cutoﬀ between conﬁdently and
786 not conﬁdently identiﬁed MTEs.
787 We then triaged the 100 metabolites into those where all of
788 their MTEs were conﬁdently identiﬁed (tMICE ≥ 1.0, green), as
789 opposed to those metabolites that contained MTEs where
790 the experimental tMICE values were <1.0 when the theoretical
791 tMICE values were ≥1.0 (red) or those metabolites that con-
792 tained MTEs where the theoretical tMICE value was <1.0 (cyan
793 in Figures 6 and 7).
794 At a metabolite level, as opposed to an MTE level, only 42
795 metabolites had all of their MTEs green (tMICE≥ 1.0, conﬁdent
796 assignment); 24 had at least one red MTE (actual tMICE < 1.0,
797 whereas theoretical ≥1.0), and a further 34 had at least one cyan
798 MTE (theoretical tMICE < 1.0) with no red MTEs. Thus, 58 of
799 the 100 metabolites had at least 1 MTE with insuﬃcient infor-
800 mation for conﬁdent assignment (Figure 7, all analyses for HSQC-
801 level data).
802 Given that nearly a quarter of MTEs had theoretical tMICE
803 values of <1.0 (cyan in Figure 6) and that nearly 60% of the
804 metabolites as a whole had at least 1 MTE without suﬃcient
805 information for conﬁdent assignment, the analysis was repeated
806 at the HMBC level to generate the corresponding theoretical
807 and experimental tMICE+ values for each MTE for comparison.
808 The only diﬀerence between the HSQC-level tMICE value and
809 the HMBC-level tMICE+ value for the same MTE is that the
810 number of HMBC connectivities observed for thatMTE is added
811 to the HSQC-level MII before dividing by the number of carbon
812 atoms in theMTE. 2D 1H, 13CHMBC data are very important in
813 metabolite identiﬁcation as it allows additional carbon-13 to
814 hydrogen connectivities to be determined over two or three
815 bonds via 2JCH and
3JCH. HMBC data allows: (1) connectivities to
816 quaternary carbons to be observed, which are otherwise generally
817 invisible, and (2) via 3JCH, connectivities through heteroatoms
818 and quaternary carbons can be observed. These newHMBC data
819 enable: (1) the acquisition of MII for MTEs which have signiﬁ-
820 cant numbers of quaternary carbons, (2) the linking of MTEs
821 to one another, which are separated by “spectroscopically silent
822 centers”, and (3) the acquisition of information on symmetrically
823 equivalent MTEs or parts of an MTE due to isotopomeric
824 breaking of MTE symmetry.
825 Similar diﬀerences to those observed for tMICE values were
826 seen between the tMICE+ values of both symmetric and non-
827 symmetric metabolites and between achiral and chiral metabo-
828 lites (see Results).
829 It is important to note that for metabolites possessing some
830 degree of symmetry, such as isovaleric acid,
831while no information could be obtained directly on the presence
832of the second methyl group in MTE2, due to molecular
833symmetry in HSQC-level experiments, in a 2D 1H, 13C HMBC
834experiment, connectivities can be seen between one methyl
835group and the other via the isotopomer H3
13C−CH−12CH3,
836with observation at the −12CH3 group. The presence of the
837H3
13C-isotope in one methyl group only (statistically very
838unlikely to observe 13C isotopes in both methyl groups) means
839that the two methyl groups are no longer symmetrically equiv-
840alent and a true, cross-methyl HMBC connectivity is seen. Thus,
841this is a third important reason for the use of HMBC data in
842metabolite identiﬁcation experiments.
843The diﬀerence between the tMICE analysis at HSQC level and
844the tMICE+ analysis at HMBC level is illustrated in Figure 7.
845In the HSQC-level tMICE analysis, 135 MTEs (62%) have
846actual tMICE values ≥1.0 (green); 29 MTEs (13%) have actual
847tMICE values <1.0 but theoretical tMICE values ≥1.0 (red);
848and 52 MTEs (24%) have theoretical tMICE values <1.0 (cyan).
849By contrast, in the tMICE+ analysis at HMBC level, 168 MTEs
850(77%) have actual tMICE+ values ≥1.0; 40 MTEs (19%) have
851actual tMICE+ values <1.0 but theoretical tMICE values ≥1.0;
852and only 8 MTEs (4%) have theoretical tMICE+ values <1.0.
853At an HMBC level, 61 metabolites now have all MTEs with
854suﬃcient identiﬁcation information for conﬁdent assignment
855(green, cf. 42 in tMICE level), but 34 still have at least one MTE
856with an actual tMICE+ < 1.0, while the theoretical tMICE+≥ 1.0
857(red, cf. 24 in tMICE analysis) and only 5 now have at least
8581 MTE with a theoretical tMICE+ of <1.0 (cyan, cf. 34 in tMICE
859analysis), with no red MTEs.
860It is important to address the issue of MTEs that do have
861tMICE+ < 1.0. In cases where the actual tMICE+ value is <1.0
862but the theoretical value is ≥1, it is possible to look for the
863missing information in other samples for conﬁrmation. In cases
864where the theoretical tMICE+ is <1.0, this is not possible and
865other approaches will be needed. We illustrate these approaches
866now with some examples from this work.
867Ketoleucine and 2-oxoglutaric acid are examples where even
868though the theoretical tMICE+ was >1.0 the actual HMBC-level
869tMICE+ values in both cases were <1.0, and in fact no infor-
870mation was obtained from MTE1 at an HMBC level in either
871case. This is because, the ﬁrst MTE in both cases is a carboxylate-
872keto group with two quaternary carbons joined together, resulting
873in no information at the HSQC level and a diﬃculty in obtaining
874HMBC-level data for samples in which metabolite concentrations
875 gare low.
876In these cases, we were fortunate to have access to female
877C57BL/6 urine samples containing higher concentrations of the
878metabolites (the original samples were all from male mice). For
879ketoleucine, female C57BL/6 mice have 2.619 (d, 7.1 Hz, CH2),
88051.1 with COSY to 2.10 (CH), TOCSY to 0.944 (CH3), and
881HMBC to 24.2 and 210.8 (ketone carbonyl), thus linking MTE1
882to MTE2 and providing information on MTE1. In addition, they
883have 0.941 (d, 6.8 Hz, CH3), 24.5 with COSY to 2.103, TOCSY
884to 2.614, and HMBC to 50.7 and 24.0 (low digital resolution in
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885 t1, so shift imprecise; cross-methyl connectivity), thus linking
886 MTE 2 to the symmetrically equivalent group in MTE3 and con-
887 ﬁrming the structure. For 2-oxoglutaric acid, female C57BL/6
888 mice have 2.448 (t, 6.8 Hz), 33.4 with COSY to 3.013 (t, 6.9 Hz),
889 38.4 and HMBC from 2.444 to 184.2 and 207.6. The HMBC
890 link from the methylene to the ketone carbon at 207.6 proves
891 the linking of MTE1 to MTE2 and conﬁrms the identity of the
892 metabolite.
893 Trimethylamine and trimethylamine-N-oxide are examples of
894 metabolites where, even at an HMBC level, it is impossible to
895 obtain any identiﬁcation information on the third MTE, which is
896 a symmetrically equivalent methyl group. HMBC data provide
897 information that there is a symmetrically equivalent methyl
898 group from the cross-methyl HMBC peaks, but it cannot deﬁne
899 that there are two of these. In these cases, the situation is made
900 more diﬃcult by the fact that there is so little information
901 available: The signals of both these metabolites comprise just one
902 singlet. Their identiﬁcation is considered safe but not deﬁnitive
903 on the basis of spectroscopic signal density and signal char-
904 acteristics arguments, as follows. The information density in the
905
1H NMR spectrum of a bioﬂuid such as urine varies with the
906 chemical shift and is not at a maximum in the region of the signals
907 from trimethylamine and trimethylamine-N-oxide. In addition,
908 the sharp singlet signals from these metabolites are relatively
909 characteristic. Nevertheless, to be prudent and avoid errors, it
910 would be recommended to conﬁrm the identities of these meta-
911 bolites by a complementary technology such as MS if they were
912 determined to be statistically signiﬁcant biomarkers in a study.
913 From the NMR spectroscopy perspective, they are considered
914 Putatively Annotated, Level 2 in the MSI notation. It is possible
915 that in other cases additional information could be obtained
916 from long-range, proton−proton coupling constants, as 4JHH, 5JHH,
917and even 6JHH couplings can be either observed directly or
918inferred from COSY experiments in bioﬂuid NMR spectra.25
919In addition, information from heteronuclear couplings such as
920
2JNH due to
14N isotopes in highly symmetrical environments25
921or 3JPH and
4JPH due to the presence of
31P in nucleotides may
922also provide additional conﬁrmatory information.
923Other approaches to the analysis are possible. One alternative
924topological measure of metabolite identiﬁcation conﬁdence at
925the HSQC level would be the topological metabolite identiﬁ-
926cation nitrogen and carbon eﬃciency index: tMINCE, which is
927equivalent to tMICE but where the number of bits of MII for an
928MTE, is divided by the total number of nitrogens with non-
929exchanging protons (NHs) plus the number of carbon atoms in
930the MTE. The analogous tMINCE+ index could be used for
931HMBC-level information. All of the information required to
932calculate this is provided in Supplementary Table S2. In this
933group of 100 metabolites, only 17 MTEs and 16 metabolites had
934nitrogens with slow-exchanging hydrogens attached (urea has
935two such MTEs). The tMINCE or tMINCE+ approaches are,
936in principle, more conservative than the tMICE or tMICE+
937approaches due to the denominator in the equation being at least
938as large or larger, but in practice not one single MTE would have
939changed classiﬁcation, that is, actual or theoretical tMINCE or
940tMINCE+ < 1.0 when tMICE or tMICE+ ≥ 1.0, respectively.
5. CONCLUSIONS AND FUTURE WORK
941The new topological approach to metabolite identiﬁcation
942conﬁdence (tMICE) presented here is an improvement upon
943the original metabolite identiﬁcation carbon eﬃciency (MICE)
944method, as it objectively monitors whether MII covers all relevant
945parts of the metabolite’s structure. It is clear when reviewing this
946more stringent approach to metabolite identiﬁcation conﬁdence
Table 3. Glossary
no. term explanation
1 HSQC 2D, heteronuclear single quantum coherence spectroscopy, allowing correlations between protons and directly attached 13C nuclei to be elucidated
(2D 1H, 13C HSQC)
2 HMBC 2D heteronuclear multiple bond correlation spectroscopy, allowing correlations between protons and 13C nuclei two to three bonds away to be
elucidated (2D 1H, 13C HMBC)
3 MTE molecular topology element: a chain or ring in a metabolite that forms part or all of the structure
4 MII metabolite identiﬁcation information
5 MICE metabolite identiﬁcation carbon eﬃciency45
•can be deﬁned at a number of levels
•at HSQC level, equals sum total of information bits from proton chemical shifts, multiplicities, coupling constants, second-order ﬂag, COSY
connectivities, and HSQC connectivities divided by the total number of carbon atoms in the metabolite, that is, equals MII at HSQC level divided
by the number of carbon atoms in the metabolite
6 MINCE metabolite identiﬁcation nitrogen and carbon eﬃciency
•can be deﬁned at a number of levels
•at HSQC level, equals sum total of information bits from proton chemical shifts, multiplicities, coupling constants, second-order ﬂag, COSY
connectivities, and HSQC connectivities, divided by the total number of carbon atoms and nonexchanging NHs in the metabolite
7 tMICE topological MICE
•can be deﬁned at a number of levels
•at HSQC level, equals sum total of information bits from proton chemical shifts, multiplicities, coupling constants, second-order ﬂag, intra- and
inter-MTE COSY connectivities, and HSQC connectivities, that is, the MII, divided by the total number of carbon atoms in the MTE
8 tMINCE topological MINCE
•can be deﬁned at a number of levels
•at HSQC level, equals sum total of information bits from proton chemical shifts, multiplicities, coupling constants, second-order ﬂags, intra-and
inter-MTE COSY connectivities, and HSQC connectivities, divided by the total number of carbon atoms and nonexchanging NHs in the MTE
9 tMICE+ topological MICE+
•equivalent to tMICE at HMBC level, and equals sum total of information bits from proton chemical shifts, multiplicities, coupling constants, second-
order ﬂag, intra- and inter-MTE COSY connectivities, HSQC connectivities, and HMBC connectivities, divided by the total number of carbon
atoms in the molecular topology element (MTE)
10 tMINCE+ topological MINCE+
•equivalent measure to tMINCE at HMBC level and equal to the total amount of information divided by the total number of carbon and
nonexchanging NHs in the MTE
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947 that, in many cases, HMBC-level information is important for
948 improved conﬁdence. This is especially the case for metabolites
949 that (i) possess MTEs that are bounded by, or composed largely
950 of, quaternary carbons or heteroatoms without slow-exchanging
951 hydrogens, or (ii) possess MTEs that are rendered wholly or
952 partly “HSQC-invisible” due to some form of symmetry, which
953 can be broken by observation of long-range connectivities from
954 an asymmetric 13C isotopomer of the metabolite in an HMBC
955 experiment.
956 The tMICE and tMICE+ methodology systematizes NMR-
957 based known metabolite identiﬁcation by (i) taking a coherent
958 topological approach, ensuring that each element of a meta-
959 bolite’s structure is considered in the analysis, (ii) using a simple
960 quantitative measure of the number of bits of MII available in
961 each MTE, and (iii) expressing that amount of MII in ratio to the
962 number of carbon atoms in each MTE: tMICE = (no. of MII
963 bits)/number of carbon atoms in the MTE.
964 In the future, automated topological analysis of all possible
965 metabolite structures would be advantageous, and this should be
966 readily computed, as the rules for topology deﬁnition are quite
967 deterministic, while aligned with the needs of NMR-based meta-
968 bolite identiﬁcation. In addition, the automated analysis of the
969 theoretical tMICE and tMICE+ scores for each MTE for each
970 metabolite should be readily computable. Metabolite identi-
971 ﬁcation would also be aided by precise and accurate NMR pre-
972 diction programs, as it would then be possible to identify many
973 metabolites, known and unknown by comparison with computed
974 as opposed to experimental chemical shifts and other parameters,
975 as experimental values are often missing.
976 The analysis of tMICE indices is recommended for all key
977 biomarkers discovered in untargeted NMR-based metabonomics
978 studies to give a measure of conﬁdence in any biological con-
979 clusions drawn from the identiﬁcation of these biomarkers.
980 We see no reason to apply the methodology to all of the known
981 metabolites identiﬁed and would advocate an approach that is as
982 simple as possible to implement and use, consistent with rigor.
983 Known metabolite identiﬁcation is a signiﬁcant issue for both
984 MS- and NMR-based metabolic proﬁling experiments. We hope
985 that the tMICE and tMICE+ approaches and variants will ﬁnd
986 utility in the ﬁeld. We expect that other researchers will seek to
987 improve on these initial proposals and also develop similar
t3 988 approaches for MS-based metabolic proﬁling.
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